S D Fine-Chem Limited Shines at CPHI India 2025 – Advancing Pharmaceutical Innovation and Collaboration

S D Fine-Chem Limited Shines at CPHI India 2025 – Advancing Pharmaceutical Innovation and Collaboration

S D Fine-Chem Limited (SDFCL), a trusted Indian manufacturer of pharmaceutical excipients, analytical reagents, and specialty chemicals, successfully participated in CPHI India 2025, held from November 25–27, 2025, at the India Expo Mart, Greater Noida, New Delhi. The three-day event served as an important platform for SDFCL to showcase its expanding excipient portfolio, regulatory capabilities, and dedication to high-quality manufacturing practices.

The SDFCL booth attracted significant attention from formulation scientists, sourcing heads, and regulatory experts from across India and abroad. Visitors engaged with our team to explore our GMP-certified range of pharmaceutical excipients, supported with complete regulatory documentation including DMF, COA, TDS, stability data, and GMP declarations.

SDFCL’s excipient portfolio covers a wide spectrum of products compliant with IP, BP, USP, Ph. Eur., and FCC standards, catering to solid, liquid, and semisolid dosage forms. Some of the featured excipients included Urea, Calamine, Sodium Lauryl Sulphate, Sodium Succinate, Propylene Glycol, Sodium Benzoate, Sodium Metabisulphite, Potassium Sorbate, Zinc Sulphate, and L-Lactic Acid — all manufactured under stringent quality systems to ensure consistency, purity, and global acceptability.

In addition to its product offerings, SDFCL highlighted its advanced analytical infrastructure that supports critical testing and global compliance requirements. Our laboratories are equipped for:

• Elemental Impurity Testing (ICH Q3D) using ICP-MS / AAS
• Residual Solvent Analysis by GC-Headspace
• Chromatographic Purity Profiling by HPLC and LC-MS
• Microbial Limit and BET Testing for excipients and intermediates
• Stability and Shelf-Life Studies under controlled conditions

These capabilities demonstrate SDFCL’s strength as a scientifically advanced, regulation-ready partner for the global pharmaceutical industry.

Throughout CPHI India 2025, our team engaged in meaningful discussions with pharma manufacturers, formulation teams, QA/QC specialists, and international distributors. Conversations focused on customized excipient development, documentation support, and collaborative partnerships to serve regulated and emerging markets alike.

SDFCL’s manufacturing facilities at Tarapur (Maharashtra) and Poicha (Vadodara, Gujarat) are certified for GMP, ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 22000:2018, FSSC 22000 & GLP, reflecting our integrated approach to quality, environmental care, and occupational safety. The company also continues to emphasize sustainability and green chemistry practices in alignment with India’s “Atmanirbhar Bharat” vision.

In addition to our excipient display, SDFCL also featured selected laboratory support equipment, including Intelligent Dispensing Peristaltic Pumps and Dual Compressor Deep Freezers, reinforcing our role as a single-source partner for laboratory and formulation support.

We extend our sincere gratitude to all visitors, customers, and partners who visited our booth during CPHI India 2025. Your encouragement and valuable feedback continue to inspire us to deliver reliable, high-purity excipient solutions that meet the evolving needs of the global pharmaceutical industry.

For more information or collaboration opportunities, contact us at: sales@sdfine.com